The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions

被引:82
作者
Seitz, RJ
Meisel, S
Moll, M
Wittsack, HJ
Junghans, U
Siebler, M
机构
[1] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Diagnost Radiol, D-4000 Dusseldorf, Germany
关键词
D O I
10.1212/01.WNL.0000129480.17345.4A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine the effect of systemic thrombolysis with low-dose recombinant tissue plasminogen activator (rtPA) and the body-weight adjusted platelet GPIIb/IIIa receptor antagonist tirofiban, the authors performed lesion volumetry on magnetic resonance perfusion and diffusion images recorded before thrombolysis and on T2-weighted magnetic resonance images on day 8. Treatment with rtPA and tirofiban (n = 13) resulted in a 50% lesion reduction (p < 0.03), while lesion reduction was less in rtPA treatment (n = 16) and absent in nontreated patients (n = 18).
引用
收藏
页码:2110 / 2112
页数:3
相关论文
共 11 条
[1]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1488
[2]   THE EUROPEAN STROKE SCALE [J].
HANTSON, L ;
DEWEERDT, W ;
DEKEYSER, J ;
DIENER, HC ;
FRANKE, C ;
PALM, R ;
VANORSHOVEN, M ;
SCHOONDERWALT, H ;
DEKLIPPEL, N ;
HERROELEN, L ;
FEYS, H .
STROKE, 1994, 25 (11) :2215-2219
[3]   Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: An open pilot study [J].
Junghans, U ;
Seitz, RJ ;
Aulich, A ;
Freund, HJ ;
Siebler, M .
CEREBROVASCULAR DISEASES, 2001, 12 (04) :308-312
[4]   Late secondary ischemic injury in patients receiving intraarterial thrombolysis [J].
Kidwell, CS ;
Saver, JL ;
Starkman, S ;
Duckwiler, G ;
Jahan, R ;
Vespa, P ;
Villablanca, JP ;
Liebeskind, DS ;
Gobin, YP ;
Vinuela, F ;
Alger, JR .
ANNALS OF NEUROLOGY, 2002, 52 (06) :698-703
[5]   A revised model of platelet aggregation [J].
Kulkarni, S ;
Dopheide, SM ;
Yap, CL ;
Ravanat, C ;
Freund, M ;
Mangin, P ;
Heel, KA ;
Street, A ;
Harper, IS ;
Lanza, F ;
Jackson, SP .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :783-791
[6]   High resolution measurement of cerebral blood flow using intravascular tracer bolus passages .2. Experimental comparison and preliminary results. [J].
Ostergaard, L ;
Sorensen, AG ;
Kwong, KK ;
Weisskoff, RM ;
Gyldensted, C ;
Rosen, BR .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) :726-736
[7]   Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke [J].
Parsons, MW ;
Barber, PA ;
Chalk, J ;
Darby, DG ;
Rose, S ;
Desmond, PM ;
Gerraty, RP ;
Tress, BM ;
Wright, PM ;
Donnan, GA ;
Davis, SM .
ANNALS OF NEUROLOGY, 2002, 51 (01) :28-37
[8]   Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke &lt;6 hours [J].
Röther, J ;
Schellinger, PD ;
Gass, A ;
Siebler, M ;
Villringer, A ;
Fiebach, JB ;
Fiehler, J ;
Jansen, O ;
Kucinski, T ;
Schoder, V ;
Szabo, K ;
Junge-Hülsing, GJ ;
Hennerici, M ;
Zeumer, H ;
Sartor, K ;
Weiller, C ;
Hacke, W .
STROKE, 2002, 33 (10) :2438-2445
[9]   Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke - Preliminary observations [J].
Seitz, RJ ;
Hamzavi, M ;
Junghans, U ;
Ringleb, PA ;
Schranz, C ;
Siebler, M .
STROKE, 2003, 34 (08) :1932-1935
[10]  
The PRISM-PLUS Investigators, 1998, NEW ENGL J MED, V339, P415